{'52WeekChange': -0.16736841,
 'SandP52WeekChange': 0.0644362,
 'address1': '10975 North Torrey Pines Road',
 'address2': 'Suite 150',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 24.15,
 'askSize': 800,
 'averageDailyVolume10Day': 121275,
 'averageVolume': 419750,
 'averageVolume10days': 121275,
 'beta': None,
 'beta3Year': None,
 'bid': 23.4,
 'bidSize': 1000,
 'bookValue': None,
 'category': None,
 'circulatingSupply': None,
 'city': 'La Jolla',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 25,
 'dayLow': 23.49,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -5.782,
 'enterpriseToRevenue': 32.972,
 'enterpriseValue': 121239640,
 'exDividendDate': None,
 'exchange': 'NGM',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 27.223,
 'fiftyTwoWeekHigh': 35,
 'fiftyTwoWeekLow': 23.06,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 2066976,
 'forwardEps': None,
 'forwardPE': None,
 'fromCurrency': None,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': None,
 'heldPercentInstitutions': None,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/aviditybiosciences.com',
 'longBusinessSummary': 'Avidity Biosciences, Inc., a biopharmaceutical '
                        'company, engages in the development of '
                        'oligonucleotide-based therapies. It develops antibody '
                        'oligonucleotide conjugates (AOC) that are designed to '
                        "treat a range of serious diseases. The company's AOC "
                        '1001 is used for the treatment of myotonic dystrophy '
                        'type 1, a rare monogenic muscle disease; to design, '
                        'engineer, and develop therapeutics that combine '
                        'tissue selectivity of monoclonal antibodies and the '
                        'precision of oligonucleotide therapies to access '
                        'previously undruggable tissue and cell types, and '
                        'target underlying genetic drivers of diseases. In '
                        'addition, it develops muscle programs, which focuses '
                        'on the treatment of muscle atrophy, duchenne muscular '
                        'dystrophy, facioscapulohumeral muscular dystrophy, '
                        'and Pompe diseases. Avidity Biosciences, Inc. was '
                        'founded in 2012 and is based in La Jolla, California.',
 'longName': 'Avidity Biosciences, Inc.',
 'market': 'us_market',
 'marketCap': 838874496,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_257084190',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -28270000,
 'nextFiscalYearEnd': 1640908800,
 'open': 24.11,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '858 401 7900',
 'previousClose': 23.68,
 'priceHint': 2,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 228.141,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 25,
 'regularMarketDayLow': 23.49,
 'regularMarketOpen': 24.11,
 'regularMarketPreviousClose': 23.68,
 'regularMarketPrice': 24.11,
 'regularMarketVolume': 63355,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 35350800,
 'sharesPercentSharesOut': 0.0185,
 'sharesShort': 137,
 'sharesShortPreviousMonthDate': None,
 'sharesShortPriorMonth': None,
 'shortName': 'Avidity Biosciences, Inc.',
 'shortPercentOfFloat': 0.0216,
 'shortRatio': 0.89,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'RNA',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': None,
 'twoHundredDayAverage': 27.223,
 'volume': 63355,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.aviditybiosciences.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '92037'}